Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

01.01.2024

1 Am J Obstet Gynecol
1 BMJ
4 Emerg Infect Dis
2 Infect Control Hosp Epidemiol
2 Int J Infect Dis
5 J Med Virol
1 J Virol
1 JAMA
1 Lancet
3 Lancet Infect Dis



    Am J Obstet Gynecol

  1. LI XF, Zhang YJ, Yao YL, Chen MX, et al
    The Association of Post Embryo Transfer SARS-CoV-2 Infection on Early Pregnancy Outcomes in In Vitro Fertilization: A Prospective Cohort Study.
    Am J Obstet Gynecol. 2023 Dec 20:S0002-9378(23)02171.
    >> Share


    BMJ

  2. MAHASE E
    England and Scotland see sharp rise in covid and flu cases as hospitals struggle.
    BMJ. 2023;383:2977.
    >> Share


    Emerg Infect Dis

  3. RECTOR A, Bloemen M, Thijssen M, Pussig B, et al
    Respiratory Viruses in Wastewater Compared with Clinical Samples, Leuven, Belgium.
    Emerg Infect Dis. 2024;30:141-145.
    >> Share

  4. HAN E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, et al
    Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020.
    Emerg Infect Dis. 2024;30:136-140.
    >> Share

  5. OGATA T, Tanaka H
    SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan (Response).
    Emerg Infect Dis. 2024;30:207.
    >> Share

  6. CHENG HY, Akhmetzhanov AR, Dushoff J
    SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan.
    Emerg Infect Dis. 2024;30:206-207.
    >> Share


    Infect Control Hosp Epidemiol

  7. KAUR SINGH H, Prakash-Asrani R, Pall A, Ray SM, et al
    Quantifying racial disparities in risk of invasive Staphylococcus aureus infection in Metropolitan Atlanta, Georgia, during the 2020-2021 coronavirus disease 2019 (COVID-19) pandemic.
    Infect Control Hosp Epidemiol. 2023 Dec 27:1-3. doi: 10.1017/ice.2023.
    >> Share

  8. WIMMER MR, Griffin M, Peterson-Weber A, Schulz LT, et al
    Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia.
    Infect Control Hosp Epidemiol. 2023 Dec 28:1-3. doi: 10.1017/ice.2023.
    >> Share


    Int J Infect Dis

  9. BOWN A, Sweed A, Catton M, Cowne JN, et al
    Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.
    Int J Infect Dis. 2023 Dec 25:S1201-9712(23)00813.
    >> Share

  10. SALMON D, Slama D, Linard F, Dumesges N, et al
    Long COVID patients continue to experience significant symptoms at 12 months and factors associated with improvement: a prospective cohort study in France (PERSICOR).
    Int J Infect Dis. 2023 Dec 21:S1201-9712(23)00798.
    >> Share


    J Med Virol

  11. LEE B, Ko JH, Kim YC, Baek JY, et al
    Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants.
    J Med Virol. 2023;95:e29329.
    >> Share

  12. LI J, Nie L, Guo C, Deng Y, et al
    Immunogenicity and safety of inactivated SARS-CoV-2 vaccines in people living with HIV: A longitudinal cohort study.
    J Med Virol. 2023;95:e29334.
    >> Share

  13. QI F, Cao Y, Shen Y, Wang H, et al
    Nasopharyngeal neutrophilic-retention signatures could predict disease progression in early SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29328.
    >> Share

  14. ALESSANDRI F, d'Ettorre G, Ciccozzi M, Migliara G, et al
    Early recognition of a superinfection: This is the problem in the critically ill COVID-19 patients.
    J Med Virol. 2024;96:e29345.
    >> Share

  15. PALOMINO-CABRERA R, Tejerina F, Molero-Salinas A, Veintimilla C, et al
    No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir.
    J Med Virol. 2024;96:e29337.
    >> Share


    J Virol

  16. KRCHLIKOVA V, Lotke R, Haussmann I, Reinisova M, et al
    Independent loss events of a functional tetherin gene in galliform birds.
    J Virol. 2023 Sep 15:e0080323. doi: 10.1128/jvi.00803.
    >> Share


    JAMA

  17. HARRIS E
    Disproportionate Death Rates Reported in US Prisons Early in the COVID-19 Pandemic.
    JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25770.
    >> Share


    Lancet


  18. How modelling can better support public health policy making: the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases.
    Lancet. 2023 Dec 20:S0140-6736(23)02758-7. doi: 10.1016/S0140-6736(23)02758.
    >> Share


    Lancet Infect Dis

  19. CONG B, Koc U, Bandeira T, Bassat Q, et al
    Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis.
    Lancet Infect Dis. 2023 Dec 20:S1473-3099(23)00630.
    >> Share

  20. ODA Y, Kumagai Y, Kanai M, Iwama Y, et al
    Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Lancet Infect Dis. 2023 Dec 20:S1473-3099(23)00650.
    >> Share

  21. HERFST S, de Vries RD
    Self-amplifying RNA vaccines against antigenically distinct SARS-CoV-2 variants.
    Lancet Infect Dis. 2023 Dec 20:S1473-3099(23)00734.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016